Balance Sheet
Cash Flow Statement
AcquisitionsAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Dividends Paid - CommonFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesSales of Property, Plant and EquipmentShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Core Laboratories (CLB) Share-based Compensation (2022 - 2025)

Core Laboratories (CLB) has 4 years of Share-based Compensation data on record, last reported at $1.3 million in Q3 2025.

  • For Q3 2025, Share-based Compensation rose 379.16% year-over-year to $1.3 million; the TTM value through Sep 2025 reached $5.6 million, down 3.69%, while the annual FY2024 figure was $3.8 million, 73.12% down from the prior year.
  • Share-based Compensation reached $1.3 million in Q3 2025 per CLB's latest filing, up from $538000.0 in the prior quarter.
  • Across five years, Share-based Compensation topped out at $9.0 million in Q1 2023 and bottomed at -$475000.0 in Q3 2024.
  • Average Share-based Compensation over 4 years is $2.0 million, with a median of $1.4 million recorded in 2023.
  • Peak YoY movement for Share-based Compensation: plummeted 129.27% in 2024, then surged 507.58% in 2025.
  • A 4-year view of Share-based Compensation shows it stood at $304000.0 in 2022, then surged by 414.8% to $1.6 million in 2023, then tumbled by 129.27% to -$458000.0 in 2024, then soared by 389.52% to $1.3 million in 2025.
  • Per Business Quant database, its latest 3 readings for Share-based Compensation were $1.3 million in Q3 2025, $538000.0 in Q2 2025, and $4.2 million in Q1 2025.